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Abstract
Background: There is increasing evidence that persistent organic pollutants (POPs) may contribute to pre-eclampsia. The
objective of this study was to evaluate the association between Polychlorinated Biphenyls (PCBs) and Polybrominated
Diphenyl Ethers (PBDEs) as POPs with pre-eclampsia.
Methods: This case–control study was performed in the three general university hospitals of Tehran University of Medical
Sciences. Serum samples were collected from cases (n = 45) who had diagnosed with preeclampsia and from control
samples (n= 70) with normal pregnancy and attended the same hospital for a routine prenatal visit at the third trimester
of pregnancy. Pollutants levels were analyzed by Gas Chromatography Mass Spectrometry (GC/MS).
Results: Mean participant age was 27.3 ± 5.39 with median 27. As the main independent variable, total POPs
manifested with adjusted OR equal to 1.54 (95 % CI: 1.26–1.87, p-value <0.0001), which was significantly associated with
pre-eclampsia. The adjusted OR proved a statistically significant association between total PCBs 1.77 (95 % CI: 1.34–2.32)
and total PBDEs (OR = 2.19; 95 % CI: 1.39–3.45, p-value = 0.001) with pre-eclampsia considering confounding variables
(maternal age, pre-pregnancy body mass index (BMI), gestational age, weight gain during pregnancy and total
lipids in maternal serum). Finally, pre-pregnancy BMI and weight gain during pregnancy had a positive association
with pre-eclampsia and gestational age yielded a negative association with pre-eclampsia in all analysis.
Conclusion: Our data indicate the association between total POPs, total PBDEs, and total PCBs with pre-eclampsia,
even after controlling for the effects of a number of potentially confounding factors. Further investigation about route
of exposure and the trend of POPs especially in pregnant women is needed.
Keywords: Persistent Organic pollutants (POPs), Polychlorinated Biphenyls (PCBs), Polybrominated Diphenyl Ethers
(PBDEs), Pre-eclampsia, Case–control study
Background
Persistent organic pollutants (POPs) are characterized by
their ability to persist in the environment, low water
and high lipid solubility, slow degradation and their
bio-magnification in the food chain [1]. Polychlorinated
Biphenyls (PCBs) and Polybrominated Diphenyl Ethers
(PBDEs) are classified as POPs.
PCB have been widely used in heat exchange fluids, in
electronic transformers and capacitors and used as an
additive in paint, carbonless copy paper, sealants and
plastics [2]. PBDEs are synthetic chemicals used as flame
retardants in a variety of consumer products such as
computer circuit boards and casings, television and radios,
furniture, textiles, automobiles and construction materials
[3]. The chemical structure and properties of PBDEs are
similar to those of PCBs, which were banned in several
countries [4].
The ability of POPs to co-distil, volatilize from landfills
into the atmosphere and resist degradation, makes
atmospheric transport of these chemicals as the primary
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mode of global distribution [5]. So people around the
world are exposed to these chemicals.
There is growing evidence that POPs contribute to
blood pressure and hypertension in general population
[6–14]. One of the most common pregnancy problems
leading to maternal and perinatal morbidity and mortality
worldwide is hypertensive disorders, that increase peri-
natal mortality fivefold especially in developing countries
[15]. Pre-eclampsia is one of the categories of hypertensive
disorders which are classified by the Working Group on
High Blood Pressure in Pregnancy [15]. Ten percent of
pregnant women have high blood pressure and pre-
eclampsia complicates 2 to 8 % of pregnancies [16].
The National High Blood Pressure Education Program
of the American College of Obstetrics and Genecology
defined pre-eclampsia as a pregnancy-specific syn-
drome usually occurs after 20 weeks’ gestation and de-
termined by increased blood pressure (>140 mm Hg
systolic or >90 mm Hg diastolic) accompanied by pro-
teinuria [17]. Despite advances in perinatal care, fre-
quency of pre-eclampsia has not changed and during
past decade, research addressing this disorder has been
increased [17].
Few studies investigated association of chemical pol-
lutants and risk of hypertensive disorders during preg-
nancy [2, 18–22] and magnitude of such effects remains
largely unknown. Evidence suggested defective vascular
remodelling of the spiral arteries in the first half of preg-
nancy causes pre-eclampsia [23] and Dubey et al. study
manifested the environmental oestrogens such as syn-
thetic xenoestrogens that are widely used in industrial
compounds like PCBs may induce abnormalities in
vascular function and structure by mimicking or antago-
nizing the vascular effects of oestardiol, leading to pre-
eclampsia [24]. Recent study also has been reviewed
dioxins and related pollutants effects on the placental
angiogenesis and vascular remodelling during embryo
and foetal development by reducing blood flow and cir-
culatory function, that possibly leading to pre-eclampsia
[25]. Since this problem is sever complication for mother
and infant and several studies have suggested that
women who develop pre-eclampsia are at increased risk
of cardiovascular disease later in life [26, 27], more
evaluation of this complication is necessary.
For research about pollutants in pregnant women it
should be noted, because of different trends of POPs in
each trimester of pregnancy [28, 29], the investigation of
POPs within a pregnancy should be limited to one tri-
mester for a more accurate evaluation. Meanwhile, pre-
vious studies reported that breastfeeding is one of the
main routes for pollutants excretion [30, 31] and
breastfeeding has a significant effect on decreasing the
levels of organochlorine pesticides and PCBs in serum
[32]. Therefore, measurement of POPs in primiparous
women gives us better estimation of pollutants in human
samples [33, 34].
On the other hand, pre-eclampsia as a heterogenous
disorder has different pathogenesis especially in nulliparous
women [17]. One study published a model estimating a
heritability of 31 % for pre-eclampsia [35]. However, studies
that investigated the relationship between chemical pollut-
ants and pre-eclampsia did not adjust family history of
pre-eclampsia in first degree relatives as an important
component. Meanwhile they did not consider parity and
history of breast feeding in pregnant women.
Therefore the objective of the present study was to
find the association of POPs (PCBs and PBDEs) with risk
of pre-eclampsia in a case–control study in primiparous
women who had not reported family history of pre-
eclampsia in first degree relatives.
Methods
Study sample
This case control study was approved by Institutional re-
view board of Tehran University of Medical Sciences
and all subjects signed their informed consent to partici-
pate in the study. The study population consisted of
pregnant women enrolled in the three general university
hospitals (Arash, Vali-e-Asr, MirzaKouchak Khan) in dif-
ferent districts of Tehran, Iran during a prenatal visit.
These hospitals were chosen in order to collect samples
from almost all districts of city.
All cases (n = 45) were selected from pregnant women
who had been diagnosed with pre-eclampsia during the
routine prenatal care. Pre-eclampsia was defined at least
two blood pressure measurement that were ≥ 90 mm Hg
diastolic or ≥ 140 mm Hg systolic within 14 days of one
another after 20 weeks of gestation accompanied by pro-
teinuria at any level. They had not reported previous ab-
normal blood pressure. Pre-eclampsia was diagnosed
and confirmed by at least two specialist physicians.
Blood pressure in all participants was measured twice
using sphygmomanometers in either right or left arms
after the woman was seated and at rest for a minimum
of 15 min by an appropriate cuff size.
Controls (n = 70) consisted of pregnant women attending
the same hospitals for a routine prenatal visit in pregnancy
with completely normal test results.
All cases and controls were primiparous mothers with
singleton baby at the third trimester of pregnancy. Par-
ticipants had not reported any of the following criteria:
previous family history of pre-eclampsia in first degree
relatives (mother, sister or daughter), family history or
self-history of diabetes, gynecology and obstetrics prob-
lems, previous history of metabolic and endocrine disor-
ders, renal failure, liver and thyroid disease, chronic
autoimmune disease, and anti-phospholipid syndrome.
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Collection of serum samples and data
Sample collection took place from September 2013 until
August 2015. Hospital nurses collected 10 ml blood
samples into two 5-mL vacuum blood collection poly-
propylene tubes from the cubital vein. The serum samples
were separated by centrifugation at 3000 g for 15 min
within 4 h and transferred to new blood tubes into two
parts. A part of serum sample was used to measure the
total cholesterol and triglyceride and the remaining parts
were stored for measuring POPs. The researcher trans-
ferred all collected samples from different hospitals to the
Vali-e-Asr hospital laboratory of the Tehran University of
Medical Sciences. All serum samples were coded with
numbers and then transferred to the laboratories for
measurement of triglycerides and cholesterol or POPs
levels and laboratory personals were blind about sub-
ject group and only the main investigator knows about
coding numbers. The samples were iced-packed and
stored at −70 ° C to avoid thawing. A staff member of
the Vali-e-Asr hospital laboratory then analyzed the
serum samples for total cholesterol and triglyceride
levels using enzymatic kits (Pars Azmoon, Iran).
The trained questioner in each hospital recorded indi-
vidual information about maternal age, pre-pregnancy
weight, height, residual status, gestational age, weight gain
during pregnancy, supplement consumption at pregnancy,
occupation, smoking and alcohol consumption, physical
activity and walking by face- to- face interview. Physical
activity was defined as having more than 10 min of any
activity per day accompanied by increased heartbeat and
breathing. Walking was expressed as having at least
10 min of walking per day and total day per week was
calculated. Pre-pregnancy body mass index (BMI) was cal-
culated as weight (before pregnancy) in kilograms divided
by height in meters squared.
Serum extraction and instrument
Serum samples were thawed on ice overnight before
preparation. The analytical procedure details for PBDEs
and PCBs were described elsewhere [36]. Briefly, the
samples were fortified with Hexachlorobenzene (internal
standard) and then mixed with 0.5 ml of pure formic
acid and ultrasonicated for 10 min. Serum and formic
acid mixture was applied to a combined SPE cartridges
comprised of poly divinyl benzene-co-N-vinyl pyrrolidone
and Phenomenex Strata-X sorbent (50:50 w/w 200 mg)
and filtered. The eluent was cleaned up by a serially com-
bined SPE cartridges including Sep-pak® Light Silica car-
tridges and Sep-Pak® plus Florisil which were placed
underneath the SPE cartridges, and after SPE conditioning
steps the analytes were eluted with dichloromethane
under vacuum. The residue was reconstituted in isooctane
and analyzed by Gas Chromatography Mass Spectrometry
(GC/MS).
PCB and PBDE congeners were analyzed using an
Agilant 6890–5973 GC-MS (Agilant Technologies, Palo
Alto, CA, USA). Split/splitless injector set at 250 °C.
GC separation was performed by a HP-5MS column,
(30× 0.25 mm i.d 0.25 μm film thickness). The GC oven
temperature was started at 90 °C and held at that
temperature for 1 min. Temperature was then in-
creased to 150 °C at a rate of 50 °C/min and held for
1 min. Finally, oven temperature was increased to 330 °C
at a rate of 8 °C/min and held for 3 min. The flow rate of
carrier gas, helium, was set at 1.0 ml/min. Ion source
and analyzer temperatures were set at 250 and 150 °C,
respectively. Transfer line temperature was set at 280 °C.
Identification and quantification of PCBs and PBDEs
Laboratory assays of POPs were performed at the accre-
dited Faroogh laboratory. In this study, we focused on the
ten most abundant PCB congeners (International Union
of Pure and Applied Chemistry (IUPAC) congeners 28, 52,
74, 99, 101, 118, 138, 153, 180 and 187) as well as eight
PBDE congeners (IUPAC congeners 28, 47, 99, 100, 153,
154, 183 and 209). PCB and PBDE standard solution
that contained our study congeners with more than
95 % purity were purchased from Accustandard (New
Haven, CT, USA). The limit of detection (LOD) for each
PCB congener was 0.05 ng/L and the LOD of each PBDE
congeners was 0.1 ng/L. The limit of quantification (LOQ)
for each PCB congener was 0.1 ng/L and the LOQ of each
PBDE congeners was 0.2 ng/L. The concentration of some
congeners in serum samples were less than LOD. We
substituted these samples with congener specific LOD di-
vided by the square root of two before analyses. Because
POPs are highly lipophilic and predominantly carried by
blood lipids, in order to lipid-standardized PCB and PBDE
concentrations, the lipid content in serum samples esti-
mated from the total cholesterol and triglycerides concen-
tration using Philips formula [37]. Therefore, the serum
concentration of PCBs and PBDEs were expressed as
nanorgrams per gram of plasma total lipids.
Statistical analyses
Statistical analyses were performed using the SPSS soft-
ware (SPSS, Version 16, SPSS, Inc., IL, USA). We tested
differences between the means by Student’s t-test or
Mann–Whitney U test, when appropriate. Categorical
variable differences were tested by Chi-square (χ2) test
or Fisher’s exact test. The significance level was set at
p-value less than 0.05, and all tests were two-sided. Total
PCBs and total PBDEs were calculated by summing con-
centrations of their congeners. Total POPs was computed
by summing concentrations of total PCBs and PBDEs.
All contaminant concentrations were continues vari-
ables for analyses. Multivariate binary logistic regression
was used to estimate Odds ratio (OR) and 95 %
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confidence interval (CI) for the associations between
PCBs, PBDEs and total POPs with pre-eclampsia. Poten-
tial confounders including maternal age (yrs), pre-
pregnancy BMI (kg/m2), gestational age (wks), weight
gain during pregnancy (kg), and total lipids in maternal
serum (mg/dl) were adjusted. Variables were selected a
priori for inclusion in multivariate models on the basis of
the association with pre-eclampsia in univariate analyses
(p-value < 0.20) or on the basis of evidence of an associ-
ation from the literature (total lipid).
Results
The response rate in normal group was 83.4 % (70/82)
and in pre-eclampsia group was 93.8 % (45/48). The
mean participants ‘age in this study was 27.3 ± 5.39 with
median 27. Table 1 summarizes the characteristics of the
study population. As we expected pre-pregnancy BMI
was statistically significant higher in pre-eclampsia group
(26.2 ± 4.86 vs 22.9 ± 4.17, p-value <0.001). None of the
participants reported any physical activity during preg-
nancy. Previous alcohol consumption was reported only
by one woman. No cases of smoker were observed in
both groups. Therefore, we reported only the number of
passive smokers in the Table 1.
All pregnant women in this study received routine
iron and folic acid supplementation during their preg-
nancy. In addition to routine supplementation, some of
the participants also received other supplements during
pregnancy such as calcium, multivitamin, or Omega-3.
As indicated in the Table 1, there was not any significant
difference in supplementation consumption between either
of the groups (p-value > 0.05).
The arithmetic mean and detection rate of each con-
gener was reported in Table 2. PCB 118, 138, 153 and
180 were detected in more than 90 % of serum samples.
Meanwhile, the detection rate of PBDE 47, 99 and 153
were more than 80 %. PCB 74 was not detected in any
samples. So it was deleted for further analysis. The dis-
tribution of total PCBs, total PBDEs and total POPs were
not normal (Kolmogrove - Smirnove test, p-value < 0.05)
and right-skewed. Table 3 manifested the arithmetic
mean for the total PCBs (PCB with nine congeners) and
total PBDEs (PBDE with eight congeners) were statistically
significant higher in pre-eclampsia group in comparison
to control (Mann- Whitney U-test; p-value < 0.001).
We assessed the possibility of correlation between con-
geners. Spearman correlations between PCB congeners
shows PCB180, 187 (correlation coefficient: r = 0.74) and
PCB 138, 153 (r = 0.80) and PCB 28, 118 (r = 0.76) were
strongly correlated with each other (all p-value <0.001).
Among PBDE congeners and across pollutants classes,
highly correlated congeners were not observed (all correl-
ation coefficient was less than 0.70).
The collinearity for all PCBs and PBDEs congeners
that were checked using variation inflammation factor
(VIF) manifested all VIF less than 5.
Table 4 shows, OR and 95 % CI of pollutants and
other variables in relation to pre-eclampsia with using
logistic regression analysis. Total POPs, total PCBs,
and total PBDEs entered the model separately (Model
1 to 3). As the main independent variable, total POPs
manifested with OR equal to 1.54 (95 % CI: 1.26-1.87,
p-value < 0.001), which was significantly associated
with pre-eclampsia. The adjusted OR proved a statisti-
cally significant association between total PCBs 1.77(95 %
CI: 1.34–2.32) and total PBDEs (OR = 2.19; 95 % CI: 1.39–
3.45, p-value = 0.001) with pre-eclampsia, too. When we
performed logistic regression analysis with total PCBs and
total PBDEs simultaneously (Model 4), the adjusted OR of
total PCBs did not change. However, total PBDEs have no
statistically significant effect on pre-eclampsia (OR = 1.52;
95 % CI: 0.90–2.58, p-value = 0.12).
Table 1 Baseline characteristics of case (pre-eclampsia) and
control groups
Variables Pre-eclampsia Control P-value
(n = 45) (n = 70)
Age (yrs) 28.2 ± 6.27 26.7 ± 4.69 0.14
Gestational age (wks) 33.6 ± 3.50 35.1 ± 3.09 0.01
Weight gain (kg) 14.4 ± 5.60 13 ± 5.48 0.17
Pre-pregnancy BMI (kg/m2) 26.2 ± 4.86 22.9 ± 4.17 <0.001
Triglyceride (mg/dl) 270 ± 101.14 263.5 ± 100.31 0.74
Total cholesterol (mg/dl) 212.7 ± 41.53 222.4 ± 48.22 0.27
Total Lipids (mg/dl) 815.2 ± 161.93 830.7 ± 174.44 0.63
Education 0.76
Master 1 (2.2) 0 (0)
Bachelor 10 (22.2) 13 (18.6)
Associate 2 (4.4) 3 (4.3)
Diploma 21 (46.7) 36 (51.4)
Under diploma 11 (24.4) 18 (25.7)
Passive smoker 14 (31.1) 15 (21.4) 0.24
Alcohol consumption 0 (0) 1 (1.4) 1
Walking (day/wk) 3.2 ± 2.84 3.5 ± 2.90 0.52
Job 0.42
Housewife 39 (86.7) 64 (91.4)
Others 6 (13.3) 6 (8.6)
Use of supplement
Routine supplementation 11 (24.4) 10 (14.3) 0.17
Routine plus Calcium 21 (46.7) 34 (48.6) 0.84
Routine plus Multivitamin 25 (55.6) 47 (67.1) 0.21
Routine plus Omega 3 4 (8.9) 11 (15.4) 0.29
Date shown as mean ± SD and numbers with percentages in parenthesis
P-value refers to t-test, chi-square test and Fisher exact test when appropriate.
All significant P-value was bolded
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Pre-pregnancy BMI and weight gain during pregnancy
had a positive association with pre-eclampsia and gesta-
tional age yielded a negative association with pre-eclampsia
in all analysis (Table 4).
Discussion
In the present study we reported the positive association
between total POPs, total PBDEs, and total PCBs and
pre-eclampsia in primiparous women who had no previous
history of pre-eclampsia in first degree relatives. We found
a positive association between pre-eclampsia and total
PCBs. Interestingly; we also discovered a stronger associ-
ation between serum concentrations of total PBDEs with
pre-eclampsia, suggesting different or additional routes of
exposure. The association remained significant, even after
controlling confounding factors.
Furthermore, when considering the interaction between
these two chemicals, the effect of PCBs was similar to pre-
vious analysis which was entered to the model separately.
However the effect of PBDEs has been decreased and
PCBs may block the toxic actions of total PBDEs (Table 4).
On the other hand comparing the low risk of total POPs
on pre-eclampsia with separate ORs of each pollutant, it
seems that the two chemicals action on the pre-eclampsia
does not occur via the same mechanism. Therefore, ex-
posure to PCBs and PBDEs does not have an additive ef-
fect on the risk of pre-eclampsia.
In contrast to our study findings, previous studies have
had different conclusions. A recent study by Savitz et al.
that was more similar to our study revealed no associ-
ation between serum level of total PCBs and risk of pre-
eclampsia [19]. A comparison of our results with this
study elicits differences in a variety of factors. First of all,
they did not consider the participants’ family history of
pre-eclampsia as a confounding variable. Secondly, they
included pregnant women regardless of parity and his-
tory of breastfeeding as one of the main routes for pol-
lutants excretion. Finally, the aforementioned research
conducted analysis with different sample size and using
categorical data instead of continues data.
Another study by Saunders et al. had results that con-
flicted with the present study. The authors reported no
evidence of association between preeclampsia and
Chlordecone as an organochlorine insecticide that has
Table 2 Arithmetic means of PCB and PBDE congeners (ng/g lipid) and detection rate of congeners in each group
Congeners Pre-eclampsia(n = 45) Control (n = 70) P-value*
Detection rate Mean ± SD Detection rate Mean ± SD
PCB28 33 (73.33) 0.03 ± 0.02 40 (57.14) 0.01 ± 0.01 <0.001
PCB52 17 (37.78) 0.014 ± 0.014 18 (25.71) 0.010 ± 0.014 0.37
PCB99 26 (57.78) 0.02 ± 0.01 29 (41.43) 0.01 ± 0.01 0.06
PCB101 18 (40) 0.01 ± 0.01 14 (20) 0.008 ± 0.007 0.05
PCB118 42 (93.33) 0.04 ± 0.02 51 (72.86) 0.02 ± 0.01 <0.001
PCB138 45 (100) 1.51 ± 1.03 70 (100) 0.81 ± 0.66 <0.001
PCB153 45 (100) 1.84 ± 1.25 70 (100) 1.13 ± 1.02 <0.001
PCB180 44 (97.78) 0.19 ± 0.17 45 (64.29) 0.05 ± 0.05 <0.001
PCB187 38 (84.44) 0.07 ± 0.07 24 (34.29) 0.02 ± 0.03 <0.001
PBDE28 35 (77.78) 0.05 ± 0.06 14 (20) 0.01 ± 0.01 <0.001
PBDE47 38 (84.44) 0.10 ± 0.12 36 (51.43) 0.05 ± 0.07 0.001
PBDE99 39 (86.67) 0.06 ± 0.07 25 (35.71) 0.02 ± 0.03 <0.001
PBDE100 10 (22.22) 0.01 ± 0.008 8 (11.43) 0.01 ± 0.004 0.71
PBDE153 45 (100) 1.88 ± 1.52 70 (100) 1.07 ± 0.83 0.001
PBDE154 6 (13.33) 0.01 ± 0.007 4 (0.54) 0.01 ± 0.003 0.35
PBDE183 24 (53.33) 0.03 ± 0.03 24 (34.29) 0.02 ± 0.02 0.13
PBDE209 7 (15.56) 0.01 ± 0.006 14 (20) 0.01 ± 0.007 0.86
Date shown as mean ± SD and numbers with percentages in parenthesis
*P-value refers to comparison of means by Mann–Whitney U-test between congener’s concentrations. Significant P-value was bolded
Table 3 Comparison between total PCBs, PBDEs and POPs
(ng/g lipid)
Pre-eclampsia Control P-value
Variables (n = 45) (n = 70)
Mean ± SD Median Mean ± SD Median
Total PCBs 3.72 ± 2.37 2.86 2.07 ± 1.66 1.50 <0.001
Total PBDEs 2.15 ± 1.64 1.51 1.20 ± 0.90 0.95 <0.001
Total POPs 5.87 ± 3.54 5.15 3.28 ± 2.23 2.70 <0.001
Significant P-value was bolded
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endocrine activities among pregnant women chronically
exposed to this chemical [2].
The association between another category of pollutants
(organophosphorous pesticide) and gestational hyperten-
sion not specifically pre-eclampsia, was reported in Italian
population, which is consistent with our study findings
[21]. Another study results, indicated that women living in
households using biomass and solid fuels have higher like-
lihood of reporting pre-eclampsia, even after controlling
for the effects of a number potentially confounding factors
[20]. The result of this study supported the hypothesis of
indoor pollutants effects on the risk of pre-eclampsia
rather than outdoor pollutants. However, some studies re-
ported the air pollution as an outdoor pollutant during
pregnancy increase the risk of hypertensive disorders of
pregnancy and pre-eclampsia [18, 22, 38].
In the present study we found the strong positive associ-
ation between PBDEs and pre-eclampsia after adjustment
of confounders. Since the PBDEs have been extensively
used in indoor applications, indoor air concentrations of
PBDEs are generally higher than outdoor levels and are
considered as significant pollutants of the indoor environ-
ment [39]. On the other hand, the present study
population consisted mostly of housewives without occu-
pational exposure to POPs due to spending most of their
time indoors. As a result, it seems that the most common
route of exposure in our population is indoor pollutants
such as air and dust.
As the capital city of Iran, Tehran is a highly pol-
luted area. As we mentioned in previous studies preg-
nancy exposure to air pollution maybe associated with
an increased risk of subsequent hypertensive disorders
[18, 22, 38]. Since our target population (cases and
controls) were living in Tehran, and distribution of
both groups were consistent in different regions of the
capital city, the exposure of both cases and controls to
air pollution was fairly similar. Future studies that in-
corporate simultaneous measurements of indoor and
outdoor pollutants are necessary to evaluate whether
outdoor pollution is the main cause of pre-eclampsia
in this population.
This study was conducted at the third trimester of
pregnancy. Because of long half-life of these chemicals
(2–10 year) [40], single measurement at the third trimes-
ter of pregnancy is reasonably representative of exposure
throughout the pregnancy.
Table 4 Maternal serum concentrations of total POPs, total PCBs, and total PBDEs in relation to odds of preeclampsia in four models
Crude OR (95 % CI) P-value Adjusted OR (95 % CI) P-value
Model 1
Total POPs 1.40 (1.18–1.65) <0.001 1.54 (1.26–1.87) <0.001
Gestational age 0.87 (0.77–0.97) 0.02 0.74 (0.62–0.89) 0.001
Pre-pregnancy BMI 1.19 (1.08–1.32) 0.001 1.29 (1.14–1.46) <0.001
Weight gain 1.05 (0.98–1.12) 0.17 1.11 (1.11–1.22) 0.04
Model 2
Total PCBs 1.54 (1.22–1.95) <0.001 1.77 (1.34–2.32) <0.001
Gestational age 0.74 (0.62–0.88) 0.001
Pre-pregnancy BMI 1.28 (1.13–1.44) <0.001
Weight gain 1.12 (1.02–1.23) 0.01
Model 3
Total PBDEs 1.89 (1.30–2.75) 0.001 2.19 (1.39–3.45) 0.001
Gestational age 0.78 (0.67–0.92) 0.003
Pre-pregnancy BMI 1.25 (1.12–1.40) <0.001
Weight gain 1.09 (0.99–1.19) 0.07
Model 4
Total PCBs 1.35 (1.05–1.74) 0.02 1.77 (1.34–2.32) <0.001
Total PBDEs 1.49 (0.97–2.30) 0.07 1.52 (0.90–2.58) 0.12
Gestational age 074 (0.62–0.88) 0.001
Pre-pregnancy BMI 1.28 (1.13–1.44) <0.001
Weight gain 1.12 (1.02–1.23) 0.01
Model 1: Total POPs as an independent variable and confounding factors entered to the model
Model 2: Total PCBs as an independent variable and confounding factors entered to the model
Model 3: Total PBDEs as an independent variable and confounding factors entered to the model
Model 4: Total PCBs and total PBDEs as independent variables entered to the model simultaneously with confounding factors
Significant P-value was bolded
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This study had some advantages. We collected samples
from primiparous women to eliminate the effect of parity
and breastfeeding as confounding factors. Meanwhile, in
order to reduce the effects of genetics and better estimate
the environmental impacts, we included women without
family history of pre-eclampsia in first degree relatives. Be-
cause we may have missed the existence of genetic back-
grounds in other relatives, a further evaluation of POPs
with genetic assessments at the same time is necessary in
future studies. Since, some studies reported the effect of the
calcium supplementation with or without co-supplements
and iron and folic acid consumption on reduction of the
risk of preeclampsia [41, 42], we considered to supple-
mentation intake during pregnancy in our participants
and we did not find any significant differences in sup-
plementation intake between two groups.
We should consider, the level of POPs are adjusted in
total lipids in the present study and during pregnancy total
cholesterol will increase on average 58 % and triglyceride
will increase on average 145 % throughout the second and
third trimester [43]. On the other hand, during pregnancy
there is a physiological increase in plasma volume [44] and
this could lead to a dilution of pollutants in the plasma of
pregnant women. Therefore, after delivery and during lac-
tation higher concentrations of pollutants are expected and
this leads to higher exposure of the baby through breast-
feeding. Further study is needed to compare the pollutants
concentrations during and after pregnancy.
This study had some limitation: Firstly, we couldn’t col-
lect enough preeclamptic samples during the study time
due to strict inclusion criteria and impossibility of sampling
in severe cases. Because, if there is severe pre-eclampsia,
pregnancy should be terminated as soon as possible to save
the mother’s life. Secondly, we have no information about
anemia in this population as a major risk for pre-eclampsia
[45]. The third limitation of our study was due to correl-
ation of POPs with each other and it is not possible to
determine the independent effect of each POPs on pre-
eclampsia and different chemicals can modify the effects
of each other on the risk of disease. Therefore, further re-
search is needed to corroborate these findings and shed
light on the biological mechanisms by which these types
of chemicals may influence the pre-eclampsia.
Conclusion
Our data indicate the association between total POPs,
total PBDEs, and total PCBs, and pre-eclampsia even
after controlling for the effects of a number of poten-
tially confounding factors. Further investigation about
route of exposure and the trend of POPs especially in
pregnant women due to the effect on their infants and
children’s health with more sample size is needed.
Even if this magnitude of association will be small, we
can find the susceptible women for prevention of pre-
eclampsia and prevention of cardiovascular disease later
in life as a major global priority.
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